• Ave. 31 No. 15802 between 158 y 190, Cubanacán, Playa, Havana. C.P. 10600, P.O. Box 6162
  • webmaster@cigb.edu.cu
  • (53) 7-2504101; (53) 7-2716022

COVID-19 vaccines and products

COVID-19 vaccines and products

Novel and traditional that are used in Cuban treatment protocols for COVID-19, such as the Abdala vaccine. Cuba deploys mass vaccination of its population with its own vaccines.

Vaccine and vaccine candidates

COVID-19Vaccines
Abdala

First vaccine against COVID-19 in Latin America.

COVID-19Vaccines
Mambisa

Anti-COVID-19 vaccine candidate, nasal application.

Therapeutic products

Biopharmaceutical productsCOVID-19
Jusvinza

To control hyperinflammation, regulate the immune response y reduce the risk of mortality.

Biopharmaceutical productsCOVID-19
Nasalferon

Interferon alfa 2b for nasal application for the prophylaxis of SARS-CoV-2 virus infection.

Biopharmaceutical productsCOVID-19
Heberon® Alfa R

Antiviral, antiproliferative and immunomodulatory.

Biopharmaceutical productsCOVID-19
HeberFERON®

Combination of interferon alpha 2b and gamma for basal cell carcinoma.

Biopharmaceutical productsCOVID-19
Hebertrans®

Contains transfer factor to treat cellular immunodeficiency, cancer, and other diseases.

Projects

CIGB 210: Therapy for COVID-19

CIGB 300: Proapoptotic peptide that acts on phosphorylation mediated by CK2